Literature DB >> 30064156

Visceral adiposity index as a useful tool for the assessment of cardiometabolic disease risk in women aged 65 to 74.

Tadeusz Dereziński1, Dorota Zozulińska-Ziółkiewicz2, Aleksandra Uruska2, Mariusz Dąbrowski3.   

Abstract

BACKGROUND: The visceral adiposity index (VAI) is considered to be a reliable indicator of adipose tissue dysfunction and cardiometabolic disease risk. The aim of this study was to evaluate its usefulness in assessing cardiometabolic risk in a sample of elderly women living in a rural-urban community in central Poland.
METHODS: A total of 365 women aged 65 to 74 years were included in this cross-sectional study. All patients were interviewed to obtain their history of diabetes mellitus, myocardial infarction, stroke, and revascularization. For all participants, anthropometric measurements were performed, then body mass index (BMI) and waist/hip ratio were calculated. Blood pressure was measured on the arm and on both ankles, and the ankle/brachial index was calculated. Blood samples were collected for the assessment of glycemia, lipid profile, and creatinine level. In patients with elevated fasting glucose, the test was repeated, or an oral glucose tolerance test was performed where appropriate. Finally, carotid intima-media thickness was measured in all women.
RESULTS: The VAI of participants was significantly correlated with a history of myocardial infarction, higher carotid intima-media thickness, diabetes, prediabetes, and impaired kidney function. Furthermore, VAI demonstrated a better correlation with these endpoints than BMI or waist circumference.
CONCLUSIONS: The VAI can be considered a useful tool for the assessment of cardiometabolic disease risk in elderly women, with a score of ≥2.71 representing the cut-off point for identifying females at high risk. In such patients, screening for cardiovascular disease, abnormal glucose metabolism, and impaired kidney function should be routine practice.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  carotid intima-media thickness; diabetes; impaired kidney function; myocardial infarction; prediabetes; visceral adiposity index

Mesh:

Year:  2018        PMID: 30064156     DOI: 10.1002/dmrr.3052

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

1.  Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome.

Authors:  Silan Zheng; Meifeng Tong; Lianqin Dong; Chunmin Du; Xin Zheng; Liying Wang; Peiying Huang; Wei Liu; Mingzhu Lin; Changqin Liu
Journal:  Endocr Connect       Date:  2020-02       Impact factor: 3.335

2.  Visceral adiposity index is associated with lung function impairment: a population-based study.

Authors:  Sunyue He; Jie Yang; Xiaoyong Li; Hongxia Gu; Qing Su; Li Qin
Journal:  Respir Res       Date:  2021-01-06

3.  Visceral adiposity index and sex differences in relation to peripheral artery disease in normal-weight adults with hypertension.

Authors:  Yumeng Shi; Chao Yu; Lihua Hu; Minghui Li; Wei Zhou; Tao Wang; Lingjuan Zhu; Huihui Bao; Ping Li; Xiaoshu Cheng
Journal:  Biol Sex Differ       Date:  2022-05-12       Impact factor: 8.811

4.  Biomarker-based visceral adiposity score and incident type 2 diabetes in the multiethnic cohort.

Authors:  Gertraud Maskarinec; Phyllis Ash Raquinio; Veronica W Setiawan; Thomas Ernst; Adrian A Franke; Steven D Buchthal; John A Shepherd; Lynne R Wilkens; Unhee Lim; Loïc Le Marchand
Journal:  Ann Epidemiol       Date:  2021-07-21       Impact factor: 6.996

5.  Visceral adiposity index is associated with silent brain infarct in a healthy population.

Authors:  Ki-Woong Nam; Hyung-Min Kwon; Han-Yeong Jeong; Jin-Ho Park; Hyuktae Kwon; Su-Min Jeong; Hyun-Jin Kim
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

6.  Abdominal aorta diameter as a novel marker of diabetes incidence risk in elderly women.

Authors:  Tadeusz Dereziński; Dorota Zozulińska-Ziółkiewicz; Aleksandra Uruska; Mariusz Dąbrowski
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.